Emerging technologies eliminating carbon emissions are becoming foundational to modern city development, transforming how ...
Myqorzo and Redemplo approved in China Approval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndromeUnderscores Sanofi's long-term commitment to ...
Velan Inc. Reports Solid Performance In The Third Quarter Of Fiscal 2026. MONTREAL, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Velan Inc. (TSX: VLN) (“Velan” or the“Company”), a world-leading manufacturer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback